Last reviewed · How we verify

NCT04986774: RISIS

Rescue Intracranial Stenting in Acute Ischemic Stroke

Completed NA Last updated 13 September 2021
What this trial tests

NA trial testing Rescue intracranial stenting in Acute Stroke in 85 participants. Completed in 29 August 2021.

Timeline
1 August 2019
Primary endpoint
29 May 2021
29 August 2021

Quick facts

Lead sponsorCan Tho Stroke International Services Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment85
Start date1 August 2019
Primary completion29 May 2021
Estimated completion29 August 2021
Sites1 location across Vietnam

Drugs / interventions tested

Conditions studied

Sponsor

Can Tho Stroke International Services Hospital

Who can join

Adults 20 to 105, any sex, with Acute Stroke or Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In acute ischemic stroke caused by intracranial large vessel occlusion, rescue intracranial stenting has been recently a treatment option to achieve recanalization in patients with the failure of mechanical thrombectomy. Nevertheless, there are few studies supporting this beneficial treatment in two cerebral circulations. We aimed to analyse whether the use of rescue intracranial stenting would improve prognosis of patients at 3 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acute Stroke

Currently open trials in the same condition.

Other Can Tho Stroke International Services Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04986774.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing